04:39 PM EST, 03/05/2024 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on March 01, 2024, sold 15,915 shares in United Therapeutics ( UTHR ) for $3,705,423. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 130 shares of the company, with 130 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1082554/000141588924006690/xslF345X03/form4-03052024_040331.xml

Price: 227.8, Change: -2.01, Percent Change: -0.87